No Data
No Data
Meikang Biotech: Report for the third quarter of 2024
medicalsystem biotechnology (300439.SZ) released its performance for the first three quarters, with a net income of 0.224 billion yuan, a year-on-year decrease of 2.43%.
Medicalsystem Biotechnology (300439.SZ) released the third quarter report for 2024, with a revenue of 14...
Medicalsystem Biotechnology Co., Ltd's (SZSE:300439) Business And Shares Still Trailing The Market
Solid Earnings May Not Tell The Whole Story For Medicalsystem Biotechnology (SZSE:300439)
Meikang Biotech: 2024 Semi-Annual Report Summary
Meikang Biotech: 2024 Semi-Annual Report